Public drug policy for children in Canada

CMAJ. 2017 Jul 31;189(30):E990-E994. doi: 10.1503/cmaj.170380.
No abstract available

Publication types

  • Review

MeSH terms

  • Canada
  • Child
  • Cost-Benefit Analysis
  • Drug Approval*
  • Health Policy*
  • Humans
  • National Health Programs*
  • Technology Assessment, Biomedical